Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea
- PMID: 8408704
- PMCID: PMC501465
- DOI: 10.1136/jcp.46.8.757
Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea
Abstract
Aims: To determine the concentrations of interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF alpha) in stools from children.
Methods: Stool samples from 14 healthy children, 32 children with inflammatory bowel disease, and 23 children with acute diarrhoea were emulsified in an equal volume of phosphate buffered saline and then centrifuged to produce a clear supernatant fluid. IL-6 and TNF alpha were measured by enzyme linked immunosorbent assay (ELISA).
Results: TNF alpha was detected in the stools of all 14 healthy children (12-130 pg/g stool), but IL-6 was detected only in three. Similar results were seen in children with inactive inflammatory bowel disease. Stool TNF alpha concentrations were raised in samples from children with active inflammatory bowel disease, but in most (11/18) of these samples IL-6 was undetectable. Stool samples contained a heat-labile factor which rapidly destroyed IL-6 immunoreactivity. Most children with diarrhoea had TNF alpha concentrations similar to those of healthy controls and most were also negative for IL-6. Three children with Shigella flexneri infection had extraordinarily high concentrations of both TNF alpha and IL-6 in their stools.
Conclusions: There is constant low grade production of TNF alpha in the intestine of healthy people. Raised values are indicative of mucosal inflammation, but are not specific. Stool IL-6 is of little use in assessing mucosal inflammation because immunoreactivity is rapidly lost in stool samples.
Similar articles
-
Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection.Gut. 1993 Feb;34(2):194-8. doi: 10.1136/gut.34.2.194. Gut. 1993. PMID: 8432472 Free PMC article.
-
Tumour necrosis factor alpha in stool as a marker of intestinal inflammation.Lancet. 1992 Jan 11;339(8785):89-91. doi: 10.1016/0140-6736(92)90999-j. Lancet. 1992. PMID: 1345871
-
Cytokines in the stools of children with complicated shigellosis.Clin Diagn Lab Immunol. 1995 Jul;2(4):492-5. doi: 10.1128/cdli.2.4.492-495.1995. Clin Diagn Lab Immunol. 1995. PMID: 7583932 Free PMC article.
-
Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease.Scand J Gastroenterol. 1998 Jun;33(6):616-22. doi: 10.1080/00365529850171891. Scand J Gastroenterol. 1998. PMID: 9669634
-
Fecal tumor necrosis factor-alpha and calprotectin as differential diagnostic markers for severe diarrhea of small infants.J Pediatr Gastroenterol Nutr. 2005 Oct;41(4):396-400. doi: 10.1097/01.mpg.0000178437.87546.06. J Pediatr Gastroenterol Nutr. 2005. PMID: 16205505
Cited by
-
Core microbiome-associated proteins associated with ulcerative colitis interact with cytokines for synergistic or antagonistic effects on gut bacteria.ISME J. 2024 Jan 8;18(1):wrae146. doi: 10.1093/ismejo/wrae146. ISME J. 2024. PMID: 39073916 Free PMC article.
-
Oral administration of avian tumor necrosis factor antibodies effectively treats experimental colitis in rats.Dig Dis Sci. 2000 Dec;45(12):2298-305. doi: 10.1023/a:1005554900286. Dig Dis Sci. 2000. PMID: 11258548
-
Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease.Br J Pharmacol. 2008 Dec;155(7):1085-92. doi: 10.1038/bjp.2008.369. Epub 2008 Sep 22. Br J Pharmacol. 2008. PMID: 18806816 Free PMC article. Clinical Trial.
-
Infliximab therapy in pediatric Crohn's disease: a review.Clin Exp Gastroenterol. 2010;3:57-63. Epub 2010 Jun 15. Clin Exp Gastroenterol. 2010. PMID: 21694847 Free PMC article.
-
Proinflammatory fecal mRNA and childhood bacterial enteric infections.Gut Microbes. 2010 Jul;1(4):209-212. doi: 10.4161/gmic.1.4.13004. Epub 2010 Jul 13. Gut Microbes. 2010. PMID: 21327027 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical